Hideho Okada, Md, Phd

This early-stage study is testing a new personalized treatment for adults with a specific type of recurrent brain cancer called glioblastoma. Doctors take a patient's own immune cells, genetically modify them in a lab to better target the cancer, and then infuse them back into th…